These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31662219)

  • 21. Endogenous and exogenous endocrine factors.
    Henderson BE
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):577-98. PubMed ID: 2691490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of breast cancer associated with oral contraception and hormone replacement therapy.
    Speroff L
    Womens Health Issues; 1992; 2(2):63-72; discussion 73-4. PubMed ID: 1535527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous estrogens and breast cancer in women with natural menopause.
    Casagrande J; Gerkins V; Henderson BE; Mack T; Pike MC
    J Natl Cancer Inst; 1976 Apr; 56(4):839-41. PubMed ID: 1255802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies.
    Verheul HA; Coelingh-Bennink HJ; Kenemans P; Atsma WJ; Burger CW; Eden JA; Hammar M; Marsden J; Purdie DW
    Maturitas; 2000 Jul; 36(1):1-17. PubMed ID: 10989237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 27. Postmenopausal hormone therapy and the risk of breast cancer in Norway.
    Román M; Sakshaug S; Graff-Iversen S; Vangen S; Weiderpass E; Ursin G; Hofvind S
    Int J Cancer; 2016 Feb; 138(3):584-93. PubMed ID: 26289549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous Hormones and Breast Cancer Risk: Contraception, Menopausal Hormone Therapy, and Breast Cancer Survivors.
    Pearlman MD
    Clin Obstet Gynecol; 2022 Sep; 65(3):510-523. PubMed ID: 35703230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk.
    Flores VA; Taylor HS
    Endocrinol Metab Clin North Am; 2015 Sep; 44(3):587-602. PubMed ID: 26316245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.
    Pike MC; Spicer DV; Dahmoush L; Press MF
    Epidemiol Rev; 1993; 15(1):17-35. PubMed ID: 8405201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.
    Colditz GA
    J Natl Cancer Inst; 1998 Jun; 90(11):814-23. PubMed ID: 9625169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy increases the risk of breast cancer.
    Colditz GA
    Ann N Y Acad Sci; 1997 Dec; 833():129-36. PubMed ID: 9616745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 36. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP; Jackisch C
    Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopausal estrogen replacement therapy and breast cancer.
    Dupont WD; Page DL
    Arch Intern Med; 1991 Jan; 151(1):67-72. PubMed ID: 1824675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.